Quarterly report pursuant to Section 13 or 15(d)

Commitment and Contingencies (Details)

v3.5.0.2
Commitment and Contingencies (Details)
Dec. 16, 2011
USD ($)
$ / shares
shares
Employment Agreement Details  
Annual base salary | $ $ 240,000
Percent of Company's revenue that Mr. Dahl entitled to receive as monthy bonus compensation 2.00%
Exercise price per share warrants entitled | $ / shares $ 0.25
Warrant for shares upon identification of bio-active agents 500,000
Warrant for shares to be issued upon upon entering into a business contract 500,000
Receives in cash payments | $ $ 500,000
Warrant for shares upon the Company entering into a co-development agreement 1,000,000
Partner provides atleast in cash or in-kind outlays | $ $ 2,000,000
Warrant for shares upon the Company entering into a co-development agreement 1,000,000
Warrant for shares upon upon the Company entering into a pharmaceutical development agreement 1,000,000